Communicating uncertainty in research for Parliament

When drawing on research evidence to inform policymaking, uncertainties abound. The COVID-19 pandemic showed how policymakers can be faced with making decisions in the context of high levels of uncertainty in a rapidly evolving situation.

Communicating uncertainty in research for Parliament

Drug Therapies for COVID-19

Research studies involving thousands of people have allowed scientists to test which drugs are effective at treating COVID-19. Several drug therapies are now available to treat people who are in hospital with COVID-19, or to prevent infections in vulnerable people becoming more serious. This briefing explains which drugs are available, the groups of people in which they are used and how they work. It also outlines the importance of monitoring the emergence of new variants and drug resistance.

Drug Therapies for COVID-19
  • Rapid response

    COVID-19: Omicron, recent developments, and the likely impact of future variants on the pandemic

    The Omicron variant of the SARS-CoV-2 virus, which causes COVID-19, has been found across the world since it was first detected in early November 2021. This article describes the characteristics of the variant and its health impacts. It also discusses vaccine effectiveness against the variant and the medium and long-term outlook for the future course of the pandemic.

  • Resource

    COVID-19 glossary

    The most common scientific terms used in research that relates to COVID-19. This glossary will help you understand materials that describe the biology of Coronavirus and the spread of COVID-19. It can assist in the reading of research papers and help you understand language used in drug and vaccine development. It also has a comprehensive list of international and UK organisations involved in public health, their institutional acronyms and descriptions of their work.

  • Rapid response

    COVID-19: The Omicron Variant

    The Omicron variant of the SARS-CoV-2 virus, which causes COVID-19, has been found across the world since it was first detected in early November 2021. This article describes the characteristics of the variant, why scientists are concerned, and the possible impact that it might have on the course of the pandemic.

  • POSTnote

    Children’s Mental Health and the COVID-19 Pandemic

    A POSTnote describing the impact of the COVID-19 pandemic on children's mental health. This briefing summarises the latest understanding from research about the effects on children throughout the pandemic, and the factors that increase vulnerability to poor mental health. It also reviews policy approaches that seek to protect children's mental health, with particular focus on recent initiatives to address this.

  • Rapid response

    Immunising children against COVID-19

    As the UK COVID-19 immunisation programme reaches all adults, the Government has announced an update to its policy on using a COVID-19 vaccine in children. So, how does COVID-19 affect children? What will the impact of vaccinating children be on preventing disease and minimising associated risks? And what do we know about public attitudes to using COVID-19 vaccines in children?

  • POSTnote

    Mental health impacts of the COVID-19 pandemic on adults

    The impact of the COVID-19 pandemic is a significant public health concern, with a growing body of research describing the effects on the population since March 2020. This POSTnote summarises the key findings from research, highlights the groups most affected and their mental health outcomes, and the limitations of current knowledge. It also discusses policy approaches to protect mental health and how healthcare services can adapt to improve outcomes.

  • POSTnote

    Childhood Obesity

    In 2019, the UK Government called childhood obesity “one of the biggest health challenges this country faces”. Childhood obesity contributes to a range of physical and mental health conditions. This POSTnote outlines current trends in childhood obesity, the impacts on children’s health and access to support. It also covers key risk factors for childhood obesity and evidence on the effectiveness of policies to address it.